[The adiponectin to leptin ratio, a still unrecognized biomarker of insulin resistance and cardiometabolic risk].
Le rapport adiponectine sur leptine, un biomarqueur d’insulino-résistance et de risque cardiométabolique encore méconnu.
adiponectin
adiponectin/leptin ratio
insulin resistance
leptin
obesity
Journal
Annales de biologie clinique
ISSN: 1950-6112
Titre abrégé: Ann Biol Clin (Paris)
Pays: France
ID NLM: 2984690R
Informations de publication
Date de publication:
01 06 2020
01 06 2020
Historique:
pubmed:
19
5
2020
medline:
24
9
2020
entrez:
19
5
2020
Statut:
ppublish
Résumé
Leptin and adiponectin are two adipokines. Their circulating concentrations, high for leptin and low for adiponectin, are predictive of insulin resistance and of an unfavorable cardiometabolic evolution in patients with obesity, metabolic syndrome or type 2 diabetes. In addition, recently, the adiponectin/leptin ratio has been proposed as an index of adipose tissue dysfunction together with threshold values for cardiometabolic risk for this index. The relevance and potential applications of the adiponectin/leptin and leptin/adiponectin ratios are discussed in the light of recent literature in this brief update.
Identifiants
pubmed: 32420886
pii: abc.2020.1559
doi: 10.1684/abc.2020.1559
doi:
Substances chimiques
Adiponectin
0
Biomarkers
0
Leptin
0
Types de publication
Journal Article
Review
Langues
fre
Sous-ensembles de citation
IM
Pagination
265-268Investigateurs
Jean-Philippe Bastard
(JP)
Jacqueline Capeau
(J)
Rim Charchour
(R)
Christine Collet
(C)
Charlotte Cuerq
(C)
Diane Dufour-Rainfray
(D)
Soraya Fellahi
(S)
Annelise Genoux
(A)
Jean Guibourdenche
(J)
Isabelle Jéru
(I)
Jean-Marc Lacorte
(JM)
Gilles Morineau
(G)
Camille Vatier
(C)
Corinne Vigouroux
(C)